Liposomal Bupivacaine in Implant Based Breast Reconstruction

Stopped early · Not applicable

Conditions studied: Breast Cancer, Postoperative Pain

In brief

Objectives: 1. To evaluate the effect of liposomal bupivacaine on postoperative pain levels. 2. To evaluate the effect of liposomal bupivacaine on postoperative opioid consumption and opioid related adverse events. 3. To evaluate the effect of liposomal bupivacaine on length of hospital stay. 4. To evaluate the effect of liposomal bupivacaine on patient satisfaction with postoperative pain control. 5. To evaluate the effect of liposomal bupivacaine on overall patient satisfaction.

Key facts

Study ID

NCT02659501

Run by

Loma Linda University

People needed

24

Starts

2015-07-01

Expected to finish

2017-07-01

Last updated by the study team

2021-01-12

Who can join

Age: 18 and older, up to 99. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women undergoing immediate unilateral or bilateral tissue-expander breast reconstruction following skin-sparing or nipple-sparing mastectomy

You may not qualify if…

• Women who are unable to give informed consent to participate in this study
• Women with a documented history of hypersensitivity reactions to local-anesthetic agents
• Women with a diagnosis of chronic pain disorders such as fibromyalgia, chronic migraine headaches, or psychiatric disorders other than depression or anxiety
• Women who are currently pregnant
• Women undergoing tissue expander based breast reconstruction with a muscle flap in combination with a tissue expander
• Women with impaired hepatic function

Where it is running

• Loma Linda University Health System — Loma Linda, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.